167 related articles for article (PubMed ID: 27491650)
1. In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist.
Lückmann M; Holst B; Schwartz TW; Frimurer TM
Mol Inform; 2016 Jan; 35(1):19-24. PubMed ID: 27491650
[TBL] [Abstract][Full Text] [Related]
2. Structure of the agonist-bound neurotensin receptor.
White JF; Noinaj N; Shibata Y; Love J; Kloss B; Xu F; Gvozdenovic-Jeremic J; Shah P; Shiloach J; Tate CG; Grisshammer R
Nature; 2012 Oct; 490(7421):508-13. PubMed ID: 23051748
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
Zhang Y; Zhu S; Yi L; Liu Y; Cui H
Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
6. The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.
Thomas JB; Navarro H; Warner KR; Gilmour B
Bioorg Med Chem Lett; 2009 Mar; 19(5):1438-41. PubMed ID: 19195889
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin induces mating in Saccharomyces cerevisiae cells that express human neurotensin receptor type 1 in place of the endogenous pheromone receptor.
Leplatois P; Josse A; Guillemot M; Febvre M; Vita N; Ferrara P; Loison G
Eur J Biochem; 2001 Sep; 268(18):4860-7. PubMed ID: 11559354
[TBL] [Abstract][Full Text] [Related]
9. Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice.
Amano T; Wada E; Yamada D; Zushida K; Maeno H; Noda M; Wada K; Sekiguchi M
Neuropsychopharmacology; 2008 Dec; 33(13):3135-45. PubMed ID: 18354386
[TBL] [Abstract][Full Text] [Related]
10. A machine-assisted flow synthesis of SR48692: a probe for the investigation of neurotensin receptor-1.
Battilocchio C; Deadman BJ; Nikbin N; Kitching MO; Baxendale IR; Ley SV
Chemistry; 2013 Jun; 19(24):7917-30. PubMed ID: 23592596
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
[No Abstract] [Full Text] [Related]
12. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
Pinnock RD; Woodruff GN
Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.
Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P
Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons.
Nalivaiko E; Michaud JC; Soubrié P; Le Fur G
Neuroscience; 1998 Oct; 86(3):799-811. PubMed ID: 9692718
[TBL] [Abstract][Full Text] [Related]
17. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.
Krumm BE; DiBerto JF; Olsen RHJ; Kang HJ; Slocum ST; Zhang S; Strachan RT; Huang XP; Slosky LM; Pinkerton AB; Barak LS; Caron MG; Kenakin T; Fay JF; Roth BL
Biochemistry; 2023 Apr; 62(7):1233-1248. PubMed ID: 36917754
[TBL] [Abstract][Full Text] [Related]
19. SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.
Huber S; Casagrande F; Hug MN; Wang L; Heine P; Kummer L; Plückthun A; Hennig M
PLoS One; 2017; 12(5):e0175842. PubMed ID: 28510609
[TBL] [Abstract][Full Text] [Related]
20. Effect of thermostable mutations on the neurotensin receptor 1 (NTSR
Nagarajan S; Alkayed NJ; Kaul S; Barnes AP
J Biomol Struct Dyn; 2020 Feb; 38(2):340-353. PubMed ID: 30706767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
